Search research articles
Contact Us
Filters
Showing results (141-150 of 525) with videos related to
Page
of 53
Sort By:
European Journal of Immunology
|
March 27, 2014
Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia
Stefan Rebhandl, Michael Huemer, Nadja Zaborsky, et al.
Onkologie
|
February 12, 2009
Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer
Brigitte Mlineritsch, Renate Schabel-Moser, Johannes Andel, et al.
British Journal of Haematology
|
December 5, 2012
Mimicking the microenvironment in chronic lymphocytic leukaemia - where does the journey go?
Daniela Asslaber, Eva M Grössinger, Tamara Girbl, et al.
The Oncologist
|
June 30, 2012
Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer
Matthias Preusser, Gerhard Fülöp, Anna Sophie Berghoff, et al.
Cancer Immunology, Immunotherapy : CII
|
September 22, 2010
Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia
Franz Josef Gassner, Lukas Weiss, Roland Geisberger, et al.
European Journal of Immunology
|
September 3, 2014
AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells
Michael Huemer, Stefan Rebhandl, Nadja Zaborsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2008
MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia
Irina Gryshchenko, Sebastian Hofbauer, Markus Stoecher, et al.
International Journal of Oncology
|
November 20, 2013
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review
Florian Hohla, Georg Hopfinger, Franz Romeder, et al.
Annals of Hematology
|
November 13, 2004
Long-term results of dose density therapy in patients with aggressive lymphoma
Michael A Fridrik, Hubert Hausmaninger, Werner Linkesch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 1, 2016
Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients
Ninon Taylor, Iris Kremser, Simon Auer, et al.
Page
of 53
Search research articles
Search
Showing results (141-150 of 525) with videos related to
Sort By:
Page
of 53
European Journal of Immunology
|
March 27, 2014
Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia
Stefan Rebhandl, Michael Huemer, Nadja Zaborsky, et al.
Onkologie
|
February 12, 2009
Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer
Brigitte Mlineritsch, Renate Schabel-Moser, Johannes Andel, et al.
British Journal of Haematology
|
December 5, 2012
Mimicking the microenvironment in chronic lymphocytic leukaemia - where does the journey go?
Daniela Asslaber, Eva M Grössinger, Tamara Girbl, et al.
The Oncologist
|
June 30, 2012
Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer
Matthias Preusser, Gerhard Fülöp, Anna Sophie Berghoff, et al.
Cancer Immunology, Immunotherapy : CII
|
September 22, 2010
Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia
Franz Josef Gassner, Lukas Weiss, Roland Geisberger, et al.
European Journal of Immunology
|
September 3, 2014
AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells
Michael Huemer, Stefan Rebhandl, Nadja Zaborsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2008
MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia
Irina Gryshchenko, Sebastian Hofbauer, Markus Stoecher, et al.
International Journal of Oncology
|
November 20, 2013
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review
Florian Hohla, Georg Hopfinger, Franz Romeder, et al.
Annals of Hematology
|
November 13, 2004
Long-term results of dose density therapy in patients with aggressive lymphoma
Michael A Fridrik, Hubert Hausmaninger, Werner Linkesch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 1, 2016
Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients
Ninon Taylor, Iris Kremser, Simon Auer, et al.
Page
of 53